4.3 Article

Modeling and predicting drug pharmacokinetics in patients with renal impairment

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Hepatic Clearance, but Not Gut Availability, of Erythromycin Is Altered in Patients With End-Stage Renal Disease

H. Sun et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)

Article Pharmacology & Pharmacy

In vitro-in vivo extrapolation of zolpidem as a perpetrator of metabolic interactions involving CYP3A

Thomas M. Polasek et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)

Article Nursing

CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASE IN CHRONIC KIDNEY DISEASE

Robert N. Foley

JOURNAL OF RENAL CARE (2010)

Review Pharmacology & Pharmacy

Population-Based Mechanistic Prediction of Oral Drug Absorption

Masoud Jamei et al.

AAPS JOURNAL (2009)

Article Pharmacology & Pharmacy

Drug Development Perspective on Pharmacokinetic Studies of New Drugs in Patients With Renal Impairment

R. L. Lalonde et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)

Review Pharmacology & Pharmacy

In vitro-in vivo Extrapolation of Transporter-mediated Clearance in the Liver and Kidney

Hiroyuki Kusuhara et al.

DRUG METABOLISM AND PHARMACOKINETICS (2009)

Article Pharmacology & Pharmacy

Quantitative Evaluation of Pharmacokinetic Inhibition of CYP3A Substrates by Ketoconazole: A Simulation Study

Ping Zhao et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2009)

Article Pharmacology & Pharmacy

Application of CYP3A4 in vitro data to predict clinical drug-drug interactions;: predictions of compounds as objects of interaction

Kuresh A. Youdim et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)

Article Pharmacology & Pharmacy

Maraviroc:: in vitro assessment of drug-drug interaction potential

Ruth Hyland et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)

Article Pharmacology & Pharmacy

Emerging evidence of the impact of kidney disease on drug metabolism and transport

T. D. Nolin et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)

Article Pharmacology & Pharmacy

Genetic Variants of the Organic Cation Transporter 2 Influence the Disposition of Metformin

I. S. Song et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)

Article Pharmacology & Pharmacy

Pharmacokinetic predictions in children by using the physiologically based pharmacokinetic modelling

F. Bouzom et al.

FUNDAMENTAL & CLINICAL PHARMACOLOGY (2008)

Article Biotechnology & Applied Microbiology

OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine

Zhi-Jun Wang et al.

PHARMACOGENETICS AND GENOMICS (2008)

Article Pharmacology & Pharmacy

Effects of genetic variation in the novel organic cation transporter, OCTN1, on the renal clearance of gabapentin

T. J. Urban et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)

Review Biochemistry & Molecular Biology

Physiologically based approaches towards the prediction of pharmacokinetics:: in vitro-in vivo extrapolation

Stefan S. De Buck et al.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2007)

Article Medicine, General & Internal

Prevalence of chronic kidney disease in the United States

Josef Coresh et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)

Review Biochemistry & Molecular Biology

Prediction of intestinal first-pass drug metabolism

Jiansong Yang et al.

CURRENT DRUG METABOLISM (2007)

Article Pharmacology & Pharmacy

Model-based drug development

R. L. Lalonde et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)

Article Pharmacology & Pharmacy

Sequential metabolism is responsible for diltiazem-induced time-dependent loss of CYP3A

Ping Zhao et al.

DRUG METABOLISM AND DISPOSITION (2007)

Review Biotechnology & Applied Microbiology

Simulation and prediction of in vivo drug metabolism in human populations from in vitro data

Amin Rostami-Hodjegan et al.

NATURE REVIEWS DRUG DISCOVERY (2007)

Article Urology & Nephrology

Role of parathyroid hormone in the downregulation of liver cytochrome P450 in chronic renal failure

Jose Michaud et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)

Review Medicine, General & Internal

Medical progress - Assessing kidney function - Measured and estimated glomerular filtration rate

Lesley A. Stevens et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Pharmacology & Pharmacy

The human intestinal cytochrome P450 pie

MF Paine et al.

DRUG METABOLISM AND DISPOSITION (2006)

Review Pharmacology & Pharmacy

Effects of renal failure on drug transport and metabolism

H Sun et al.

PHARMACOLOGY & THERAPEUTICS (2006)

Article Pharmacology & Pharmacy

Metabolism of repaglinide by CYP2C8 and CYP3A4 in vitro:: Effect of fibrates and rifampicin

LI Kajosaari et al.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2005)

Article Chemistry, Medicinal

Physiologically based pharmacokinetic modeling 1: Predicting the tissue distribution of moderate-to-strong bases

T Rodgers et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2005)

Article Pharmacology & Pharmacy

Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics

M Niemi et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)

Review Medicine, General & Internal

Drug dosing in chronic kidney disease

S Gabardi et al.

MEDICAL CLINICS OF NORTH AMERICA (2005)

Article Urology & Nephrology

The epidemiology of chronic kidney disease

RC Atkins

KIDNEY INTERNATIONAL (2005)

Article Urology & Nephrology

Predictive performance of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for estimating renal function

M Froissart et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)

Article Pharmacology & Pharmacy

Power, selection bias and predictive performance of the population pharmacokinetic covariate model

J Ribbing et al.

JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2004)

Article Urology & Nephrology

Measured and estimated GFR in healthy potential kidney donors

AD Rule et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2004)

Article Chemistry, Medicinal

Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination

LM Berezhkovskiy

JOURNAL OF PHARMACEUTICAL SCIENCES (2004)

Letter Pharmacology & Pharmacy

Cytochrome P450 3A expression and activity in the human small intestine

JS Yang et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)

Review Biochemistry & Molecular Biology

Drug metabolism in chronic renal failure

V Pichette et al.

CURRENT DRUG METABOLISM (2003)

Article Pharmacology & Pharmacy

Pharmacokinetics of rosiglitazone in patients with varying degrees of renal insufficiency

MC Chapelsky et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2003)

Review Urology & Nephrology

Hepatic drug metabolism and transport in patients with kidney disease

TD Nolin et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2003)

Review Urology & Nephrology

The effect of chronic renal failure on hepatic drug metabolism and drug disposition

AW Dreisbach et al.

SEMINARS IN DIALYSIS (2003)

Article Urology & Nephrology

Iron status and hemoglobin level in chronic renal insufficiency

CY Hsu et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)

Letter Gastroenterology & Hepatology

The effects of portal shunts on intestinal cytochrome P450 3A activity

A Rostami-Hodjegan et al.

HEPATOLOGY (2002)

Article Urology & Nephrology

Downregulation of intestinal cytochrome P450 in chronic renal failure

FA Leblond et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)

Article Pharmacology & Pharmacy

The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil citrate

GJ Muirhead et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)

Article Medicine, General & Internal

Insulinotropic meglitinide analogues

A Dornhorst

LANCET (2001)

Article Pharmacology & Pharmacy

Predicting the impact of physiological and biochemical processes on oral drug bioavailability

B Agoram et al.

ADVANCED DRUG DELIVERY REVIEWS (2001)

Article Pharmacology & Pharmacy

Pharmacokinetics of repaglinide in subjects with renal impairment

TC Marbury et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)